Aarey Drugs & Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

33.75 -1.30 ▼-3.7%

30 January 2023, 04:01:00 PM
Volume: 7,191

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aareydrugs.com
Market Cap 86.05 Cr.
Enterprise Value(EV) 109.89 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.62 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 20.93 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 45.92 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.74 Calculated using Price: 33.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.54 Cr. 25,384,684 Shares
FaceValue 10
Company Profile
Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.71%
1 Week
-9.40%
1 Month
-13.02%
3 Month
-11.18%
6 Month
-6.25%
1 Year
-34.02%
2 Year
+25.70%
5 Year
-41.10%
10 Year
-29.83%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.10 3.12 3.58 12.90 9.80 8.07 6.65 6.98 6.30
Return on Capital Employed (%) 5.83 6.69 7.23 22.21 14.14 12.05 8.48 9.46 9.86
Return on Assets (%) 0.98 0.98 1.07 4.09 3.96 4.15 3.41 3.05 2.74

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 35 35 37 49 80 87 92 99 114 117
Non Curr. Liab. 0 0 2 1 2 1 3 1 5
Curr. Liab. 72 80 88 92 88 58 100 131 130 107
Minority Int.
Equity & Liab. 107 115 125 143 170 146 194 233 245 228
Non Curr. Assets 5 6 8 13 13 13 13 15 19 19
Curr. Assets 102 109 117 130 157 133 181 218 226 210
Misc. Exp. not W/O 0 0
Total Assets 107 115 125 143 170 146 194 233 245 228

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 200 213 246 396 349 355 300 348 493 454
Other Income 2 3 3 3 3 4 7 7 3 3
Total Income 201 216 249 399 352 359 307 355 495 457
Total Expenditure -198 -212 -245 -386 -341 -347 -297 -344 -481 -446
PBIDT 3 4 4 13 11 12 10 12 14 11
Interest -1 -1 -2 -4 -2 -2 -2 -2 -2 -2
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -2 -2
Taxation 0 0 -1 -3 -2 -2 -1 -2 -3 -3
Exceptional Items
PAT 1 1 1 5 6 7 6 7 7 4
Adjusted EPS 1 1 1 3 3 3 2 3 3 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 3 0 3 6 1 -20 1 3 5 -4
Cash Fr. Inv. -3 2 -2 -3 -5 -1 -1 -1 -3 -2
Cash Fr. Finan. -1 -1 -2 -2 4 23 -2 -2 -2 6
Net Change -1 0 -1 1 -1 2 -3 0 0 0
Cash & Cash Eqvt 1 1 0 2 1 3 0 1 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 49.38 49.38 49.38 49.38 48.05 48.06 50.03 50.03 50.03
Public 50.62 50.62 50.62 50.62 51.95 51.94 49.97 49.97 49.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Regulation 74(5) of SEBI (DP) Regulations 2018.
Fri, 30 Dec 2022
Closure of Trading Window
Closure of Trading window
Thu, 17 Nov 2022
Regulation 23(9) Of SEBI (LODR) Regulation 2015.
Regulation 23(9) of SEBI (LODR) Regulation 2015.

Technical Scans View Details >>

Mon, 30 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Aarey Drugs & Pharmaceuticals Ltd.

What is Aarey Drugs & Pharma share price?
Can I buy Aarey Drugs & Pharma shares now?
What is the Market Cap of Aarey Drugs & Pharma?
What are the key metrics to analyse Aarey Drugs & Pharma?
What is the 52 Week High and Low of Aarey Drugs & Pharma?
What is the trend of Aarey Drugs & Pharma share price?